Skip to main content
. Author manuscript; available in PMC: 2014 Sep 22.
Published in final edited form as: Ann Oncol. 2009 Nov 4;21(3):646–654. doi: 10.1093/annonc/mdp363

Table 4. Hazard ratio (95% confidence intervals) for a 1 standard deviation (6 cm) increase in height in relation to selected cancer outcomes – overall and with 3 yr left censoring.

Sex Overall (N=506,648) With 3 yr. left censoring
(N=482,438)
No. of deaths HR (95% CI) No. of deaths HR (95% CI)
All malignancies M
F
5232
2265
1.05 (1.02, 1.08)
1.09 (1.05, 1.14)
3479
1664
1.08 (1.03, 1.14)
1.21 (1.12, 1.30)
Intestine M
F
401
276
1.09 (1.00, 1.20)
1.11 (0.99, 1.25)
293
220
1.16 (1.01, 1.33)
1.27 (1.06, 1.52)
Liver M
F
800
126
0.97 (0.90, 1.04)
1.26 (1.05, 1.52)
511
80
0.96 (0.83, 1.12)
2.02 (1.32, 3.10)
Lung M
F
1226
332
1.06 (1.00, 1.12)
1.08 (0.97, 1.21)
738
229
1.10 (1.00, 1.21)
1.24 (1.04, 1.49)
Breast M
F
*
318

1.11 (0.99, 1.24)
*
228

1.23 (1.04, 1.45)
Stomach M
F
608
233
1.04 (0.96, 1.13)
1.11 (0.96, 1.27)
391
1.06 (0.87, 1.29)
1.02 (0.72, 1.43)
Prostate M
F
274** 1.06 (0.95, 1.18)
207** 1.16 (0.98, 1.37)

All hazard ratios are age, study, and year of birth adjusted

*

too few events to run analyses

**

not applicab